Motley Fool Australia
  •  

    Notifications

    Scott

    Wondering where you should invest $1,000 right now?

    Scott Phillips just released his 5 best stocks to buy right now and you could grab the names of these stocks instantly!

    Learn More
  • Log Out
  • Menu
  1. Stocks
    2. /
  2. BioNTech Se (NASDAQ: BNTX)
    3. /

BioNTech Se (NASDAQ: BNTX) Share Price and News

$102.02 $-18.52 (-15.4%) Saturday, 26 April 2025 at 6:00:00 am Australian Eastern Standard Time

BioNTech Se Chart and Price Data

Created with Highcharts 11.4.3BioNTech Se PriceZoom1M3M6MYTD1Y5Y10YALL→www.fool.com.au

About BioNTech Se

Last updated 26-04-2025, 06:00:00am AEST
Current Price $102.02
Change $-18.52 (-15.4%)
Close Price $102.02
Open Price $118.73
Bid $102.30
Ask $103.00
Day Range $93.17 - $118.73
Year Range $76.53 - $131.49
Volume 6,438,866
Average Volume 1,034,655
Market Cap $24,481,841,400.00
Earnings Per Share $-3.04

BioNTech Se (NASDAQ: BNTX)
Latest News

A nurse administers a vaccine into the arm of a woman wearing a mask.
International Stock News

2 Nasdaq stocks bucking Monday's market drop

| Dan Caplinger

The Nasdaq Composite continued to lose ground, but these stocks held up.

Read more »

four excited doctors with their hands in the air
ETFs

Expert reveals top pandemic ETF play – up 58% in 12 months

| Bernd Struben

COVID variants are likely to drive longer-term demand for mRNA vaccines.

Read more »

A happy doctor in a white coat dancing due to his excitement over the EBOS acquisition
Healthcare Shares

Why the IDT (ASX:IDT) share price is rocketing 25% on Wednesday

| Marc Sidarous

The company claims it can make 100 million doses of mRNA vaccine within 18 months.

Read more »

man receiving covid 19 vaccine moderna biontech
International Stock News

Better biotech stock: Moderna vs. BioNTech

| Jason Hawthorne

The two companies behind the gene-based COVID vaccines are a lot different than you might think.

Read more »

health care worker giving a woman a COVID 19 vaccine
International Stock News

With COVID-19 variant threats rising, why are vaccine stocks falling?

| Dan Caplinger

Stock markets moved slightly higher despite general worries.

Read more »

woman receiving vaccine
International Stock News

3 reasons to buy BioNTech, and 1 reason to sell

| Jason Hawthorne

Despite the vaccine windfall and an impressive pipeline, shareholders might need the company's encore sooner than expected.

Read more »

Two laboratory researchers in white coats and gloves sit side by side with scientific equipment and a computer screen conducting medical related research.
International Stock News

Why BioNTech trounced the Market on Tuesday

| Eric Volkman

Shareholders might be getting a small present from the company before long.

Read more »

woman receiving covid 19 vaccine
International Stock News

If you thought these 2 big Nasdaq winners were done, think again

| Dan Caplinger

On a strong day for the Nasdaq, two highfliers stood out.

Read more »

teen showing that she has received her covid vaccination
International Stock News

Moderna files for FDA approval of its COVID vaccine in teens

| Todd Campbell

The company hopes to secure Emergency Use Authorization for its vaccine in children ages 12 to 18.

Read more »

A medical researcher in a white coat holds laboratory equipment and smiles.
International Stock News

Moderna's teen COVID-19 vaccine trial hits high marks

| Cory Renauer

The company should submit its request for the FDA to authorize the use of its vaccine in those 12 and…

Read more »

vaccine
International Stock News

BioNTech is no longer a buy, says analyst

| Eric Volkman

A Bryan Garnier prognosticator increases her price target despite the recommendation chop.

Read more »

health prffesional giving someone a vaccine
International Stock News

Pfizer and BioNTech's COVID-19 vaccine authorized by the FDA for adolescents

| Brian Orelli, PhD

Parents are pleased, but the move won't change much for the drug companies from a financial perspective.

Read more »

Profile

since

Note